We’re developing digital
treatments for people living with gastrointestinal conditions.

A Global Problem

1 in 5 people in the U.S. lives with a gastrointestinal (GI) condition. Worldwide, more than 1 billion people are affected. Mahana is developing clinically validated software programs to address these conditions.

A Whole New Kind of GI Treatment

Our digital treatments aim to provide physical and psychological support that will be clinically proven to help patients feel better.

Our Treatments

Working with expert clinicians, designers, and engineers, we aim to develop digital treatments that are empowering, personalized, and effective.

By Patients for Patients

Our own GI journeys have inspired our treatments. And we're continually collaborating with, and seeking input from people living with GI conditions.

Clinically Validated

We're committed to testing our programs in rigorous clinical trials to validate that they will improve GI symptoms and health-related quality of life.

Private + Secure

We're building our treatments with data security and a commitment to protecting patient privacy constantly on our mind.

Regulatory Clearance

As clinical trials validate our programs, we seek clearance from the FDA and other regulatory agencies to make our programs available in the U.S. and abroad.


Whenever we receive an FDA-authorization, as we have for Parallel, doctors are able to prescribe our programs for their patients.

Introducing Parallel™

A clinically validated, FDA-authorized digital program for IBS.

Learn More